- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02495584
D-Light Intervention (D-Light)
January 14, 2016 updated by: University of Ulster
D-Light Intervention: A Randomised Controlled Human Intervention Study to Assess the Impact of Vitamin D From Milk and Supplements on Functional Health Outcomes and Future Vitamin D Synthesis From UV Exposure
Vitamin D insufficiency has become a global concern, with low vitamin D status associated with bone disorders, cardiovascular disease and certain cancers.
The United Kingdom (UK) and Ireland are at particular risk of vitamin D deficiency owing to the northerly latitude, increased use of sunscreen, decreased sun exposure and a high level of cloud cover.
A recent survey in the UK showed that more than 50% of UK adults have insufficient vitamin D status, with lower levels noted in the winter months.
Variations in vitamin D status have been known to vary between summer and winter, owing to our northern latitude (52-55°N) the Ultraviolet (UV)-B intensity in Northern Ireland is inadequate to promote the dermal synthesis of vitamin D during the winter months, causing us to rely on dietary sources.
The aim of this intervention is to investigate the main effects of vitamin D3-fortified milk and supplemental vitamin D3 on vitamin D status and functional health outcomes during the winter, and how this intervention will affect subsequent dermal synthesis of vitamin D from UV exposure.
Participants will be recruited from the local community.
Blood samples will be collected from each participant at two timepoints (September/October and March/April).
Pre- and post-intervention blood pressure, grip strength, height, weight, waist and hip circumferences will be measured, in addition participants will undergo a dual energy x-ray absorptiometry (DXA) scan to assess body composition and bone mineral density.
Information on general health, lifestyle, physical activity, dietary intake and typical behaviours in the sun will be collected.
Following the dietary intervention, a subset of participants will be invited to participate in a follow-up study, examining UV exposure during the summer months, when they will wear a personal wrist dosimeter for 1 month, complete a sun dairy and provide 2 additional blood samples.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Coleraine, United Kingdom, BT52 1SA
- Human Intervention Studies Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 20-40 years old
- Apparently healthy
- Living on the island of Ireland
Exclusion Criteria:
- Below 20 years and aged 40 years or above
- Not living on the island of Ireland
- Pregnant or lactating women and those planning to become pregnant
- Individuals who have been taking a vitamin D or calcium containing supplement in the previous three months
- Those with food intolerances or allergies that would affect their ability to consume study milk
- Individuals following a diet which excludes milk (e.g. vegans)
- Those with a diagnosed chronic medical condition or on prescribed medication known to effect vitamin D metabolism
- Those who are planning a sun holiday during the winter months (Oct-Mar)
- Adults with learning, or any other difficulties that would prevent them from completing the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment 1
500ml fortified milk (10µg vitamin D3) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks
|
|
Experimental: Treatment 2
500ml fortified milk (10µg vitamin D3) +1 supplement capsule (placebo) daily for 24 weeks
|
|
Experimental: Treatment 3
500ml unfortified milk (placebo) +1 supplement capsule (10µg vitamin D3) daily for 24 weeks
|
|
Placebo Comparator: Treatment 4
500ml unfortified milk (placebo) +1 supplement capsule (placebo) daily for 24 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in vitamin D status (25-hydroxyvitamin D serum concentration)
Time Frame: Baseline + post-intervention (24weeks)
|
Blood analysis
|
Baseline + post-intervention (24weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in body composition
Time Frame: Baseline + post-intervention (24weeks)
|
Assessed by dual energy X-ray absorptiometry (DXA)
|
Baseline + post-intervention (24weeks)
|
Change in muscle strength
Time Frame: Baseline + post-intervention (24weeks)
|
Assessed by grip strength
|
Baseline + post-intervention (24weeks)
|
Change in inflammation status
Time Frame: Baseline + post-intervention (24weeks)
|
Blood analysis
|
Baseline + post-intervention (24weeks)
|
Change in lipid profile
Time Frame: Baseline + post-intervention (24weeks)
|
Blood analysis
|
Baseline + post-intervention (24weeks)
|
Change in glucose levels
Time Frame: Baseline + post-intervention (24weeks)
|
Blood analysis
|
Baseline + post-intervention (24weeks)
|
Change in insulin concentrations
Time Frame: Baseline + post-intervention (24weeks)
|
Blood analysis
|
Baseline + post-intervention (24weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UV exposure (follow-up)
Time Frame: 8 weeks post-intervention (32-40 weeks)
|
Assessed by UV wrist monitors
|
8 weeks post-intervention (32-40 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
May 11, 2015
First Submitted That Met QC Criteria
July 10, 2015
First Posted (Estimate)
July 13, 2015
Study Record Updates
Last Update Posted (Estimate)
January 15, 2016
Last Update Submitted That Met QC Criteria
January 14, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13/NI/0091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on 25-hydroxyvitamin D Concentration (Vitamin D Status)
-
University College CorkCompletedVitamin D Status as Reflected by Serum 25-hydroxyvitamin DIreland
-
King Faisal Specialist Hospital & Research CenterCompletedVitamin D Deficiency | 25-Hydroxyvitamin D ConcentrationSaudi Arabia
-
University of UlsterNorthern Ireland Executive; HSC Public Health AgencyCompletedVitamin D Status | Vitamin D ConcentrationUnited Kingdom
-
University of Eastern FinlandDSM Nutritional Products, Inc.CompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
University of Eastern FinlandCompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
Applied Science Private UniversityCompleted
-
Wake Forest University Health SciencesCompletedLow 25-hydroxyvitamin D ConcentrationsUnited States
-
University of MichiganCompleted
-
University of SurreyCompletedSerum 25-hydroxyvitamin D Concentrations (25OHD)United Kingdom
-
University of HelsinkiUniversity College Cork; Finnish Institute for Health and Welfare; Technical...CompletedSerum 25-hydroxyvitamin D Concentrations (25OHD)Finland
Clinical Trials on Fortified milk (10µg vitamin D3)
-
Gadjah Mada UniversityUnknown
-
University of AarhusRecruitingVitamin D Deficiency | Pre-Eclampsia | Fetal Growth Retardation | Gestational DiabetesDenmark
-
International Centre for Diarrhoeal Disease Research...University of California, Davis; Nestlé FoundationCompleted
-
Hospices Civils de LyonCompletedCardiometabolic RiskFrance
-
Société des Produits Nestlé (SPN)CompletedNutritional Status | Child Nutrition Sciences | ToddlersPhilippines
-
NestléCompletedGrowth | Learning | ToddlersPhilippines
-
Instituto Nacional de Salud Publica, MexicoMead Johnson NutritionCompletedUndernutritionMexico
-
FrieslandCampina WAMCO Nigeria PLCLagos State UniversityUnknownEnterobacteriaceae Infections | Nutritional Deficiency | Iron-deficiency Anemia | Nutritional Stunting | Nutritional Wasting | Malnutrition; Mild
-
National Center for Research Resources (NCRR)Baylor College of MedicineCompletedSepsis | Necrotizing EnterocolitisUnited States
-
Indonesia UniversityLudwig-Maximilians - University of MunichCompletedGestational Age and Weight Conditions | Breast Feeding, Exclusive | Low; BirthweightIndonesia